Amino acid-induced impairment of insulin sensitivity in healthy and obese rats is reversible by Jeganathan, Senthure et al.
ORIGINAL RESEARCH
Amino acid-induced impairment of insulin sensitivity in
healthy and obese rats is reversible
Senthure Jeganathan, Abdikarim Abdullahi, Sana Zargar, Naomi Maeda, Michael C. Riddell &
Olasunkanmi A. J. Adegoke
School of Kinesiology and Health Science and Muscle Health Research Centre, York University, Toronto, Ontario, Canada
Keywords
Glucose metabolism, insulin resistance,
leucine, skeletal muscle.
Correspondence
Olasunkanmi A. J. Adegoke, School of
Kinesiology and Health Science, 4700 Keele
Street, Toronto Ontario M3J 1P3 Canada.
Tel: 416-736-2100 (ext.) 20887
Fax: 416-736-5774
E-mail: oadegoke@yorku.ca
Funding Information
This project was supported by grants from
the Natural Science and Engineering
Research Council of Canada, and York
University, Toronto Canada (to O. A. J. A.).
Received: 27 May 2014; Accepted: 2 June
2014
doi: 10.14814/phy2.12067
Physiol Rep, 2 (7), 2014, e12067,
doi: 10.14814/phy2.12067
Abstract
High-protein diets (HPDs) promote weight loss but other studies implicate
these diets and their constituent amino acids (AAs) in insulin resistance. We
hypothesized that AA-induced insulin resistance is a temporal and reversible
metabolic event. L6 myotubes were serum deprived for 4 h and then incu-
bated in AA and/or insulin (100 nmol/L). Another group of cells was incu-
bated overnight in AA + insulin, starved again, and then reincubated with AA
and insulin. Mammalian (mechanistic) target of rapamycin complex 1
(mTORC1) signaling and glucose uptake were then measured. Healthy or
insulin-resistant rats were gavaged with leucine (0.48 g/kg) and insulin sensi-
tivity was examined. In myotubes, incubation with AA and insulin signifi-
cantly (P < 0.05) increased the phosphorylation of the mTORC1 substrate
ribosomal protein S6 kinase 1 (S6K1, T389) and of insulin receptor substrate
1 (IRS-1, serine residues), but suppressed insulin-stimulated glucose uptake
by 40% (P < 0.01). These modifications were mTORC1-dependent and were
reversible. In vivo, leucine gavage reversibly increased S6K1 phosphorylation
and IRS-1 serine phosphorylation 5- to 12-fold in skeletal muscle and
impaired insulin tolerance of glucose (P < 0.05) in lean rats. In insulin-resis-
tant rats, the impairment of whole blood glucose and AA metabolism induced
by leucine gavage (0.001 < P < 0.05) was more severe than that observed in
lean rats; however, the impairment was reversible within 24 h of treatment. If
these data are confirmed in long-term studies, it would imply that the use of
leucine/HPD in treating metabolic diseases is unlikely to have lasting negative
effects on insulin sensitivity.
Introduction
High-protein diets (≥25% energy intake as proteins) (Ei-
senstein et al. 2002) have been used in the management
of obesity. The mechanisms of action of these diets
include increased thermogenesis, enhancement of satiety
(Westerterp-Plantenga et al. 1999), and increased loss of
body fat mass (Layman et al. 2005). Amino acids (AAs)
from dietary proteins not only serve as substrates for
body protein synthesis but can also activate the mamma-
lian (mechanistic) target of rapamycin mTOR complex 1
(mTORC1) signaling, a pathway that is essential in
regulating muscle mass (reviewed in Adegoke et al. 2012;
Efeyan et al., 2012a,b). In this regard, the most well-char-
acterized substrates of mTORC1 are ribosomal protein S6
kinase 1 (S6K1) and eukaryotic initiation factor 4E
(eIF4E)-binding proteins (4E-BPs) (Dowling et al. 2010;
Thoreen et al. 2012).
At odds with the benefits attributed to high-protein
diets are data that implicate them in the pathogenesis of
insulin resistance, a metabolic derangement that can lead
to type 2 diabetes, cardiovascular disease, and some can-
cers. Some studies have shown a link between high-protein
diets and glucose intolerance, increased gluconeogenesis,
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insulin resistance, and type 2 diabetes (Lariviere et al.
1994; Linn et al. 2000; Schulze et al. 2003; Song et al.
2004). Amino acids, particularly leucine and other
branched chain amino acids (BCAA), which are potent
activators of mTORC1, have been identified as major play-
ers in this (Krebs et al. 2002; Newgard et al. 2009; Adams
2011). In addition to stimulating muscle anabolism, acti-
vated mTORC1/S6K1 can phosphorylate insulin receptor
substrate 1 (IRS-1) on serine residues, which can lead to
insulin resistance (Tremblay et al. 2007).
A feature of many signaling pathways is the reversibil-
ity of the signaling cascade. For example, following the
initiation of insulin signaling, protein tyrosine phospha-
tase 1B (PTB1B), suppressor of cytokine signaling 1
(SOCS1) and SOCS3 are activated, leading to reduced
phosphorylation of IRS1 (Shepherd 2005). In addition,
activation of phosphate and tensin homolog on chromo-
some-10 (PTEN) converts phosphatidylinositol 3,4,5-tri-
phosphate (PIP3) to PIP2 (Song et al. 2012), leading to
the suppression of AKT signaling. Although deregulation
of these phosphatases may lead to insulin resistance,
their functions are a part of reversible switches critical
for normal insulin action (Jin and Pawson 2012). It is
likely that amino acid-induced effect of mTORC1/S6K1
in phosphorylating IRS-1 and the attendant insulin resis-
tance are normal but reversible physiological events, at
least in healthy individuals. However, the dynamics of
mTORC1/S6K1 effect on IRS-1 serine phosphorylation
and insulin resistance remains to be examined. Here, our
objectives were to (1) examine the time course of the
effect of leucine-enriched AA medium and/or insulin on
mTORC1 signaling and the associated IRS-1 serine phos-
phorylation and (2) examine the dynamics of the effect
of this AA mixture or leucine on glucose transport in
myotubes and on whole body insulin resistance of glu-
cose and amino acid metabolism in healthy and insulin-
resistant rats.
Materials and Methods
Reagents
Fetal bovine serum and antibiotic–antimycotic prepara-
tions were purchased from Life Technologies (Burlington,
Ontario, Canada). Immobilon Western Horseradish Per-
oxidase (HRP) chemiluminescence substrate was obtained
from Millipore Corporation (Billerica, MA); L-leucine,
phosphatase and protease inhibitor cocktails from Sigma-
Aldrich (St. Louis, MO); a-Eagle’s minimal essential
medium (AMEM) and trypsin from Wisent (St Bruno,
Quebec, Canada); and L-leucine dehydrogenase from Calbio-
chem (EMD Millipore). Amino acid-free medium (RPMI
1640) was obtained from US Biological (Swampscott, MA).
Glucose solutions and glucose/lactate buffers were obtained
from Interscience (Markham, ON Canada).
Antibodies
Antibodies to phospho (ph)-S6K1 (T389), total S6K1,
ph-IRS-1 (S307/612, S636/639), total IRS-1, ph-Akt
(T308), and HRP-conjugated secondary antibodies (anti-
rabbit and anti-mouse) were purchased from Cell Signal-
ing Technology (Danvers, MA). Antibodies to c tubulin
were obtained from Sigma-Aldrich.
Amino acid and insulin activation of
mTORC1/S6K1 in myotubes
L6 myotubes were starved for 4 h in serum-free AMEM,
following which cells were incubated in either serum- and
AA-free medium or leucine-enriched AMEM (final con-
centration of leucine: 800 lmol/L), for 30 min (Fig. 1A,
top). We used a leucine-enriched medium because of the
demonstrated effects of this amino acid on mTORC1 sig-
naling (Newgard 2012). After this, incubation with the AA
mixture continued in either the presence or the absence of
100 nmol/L insulin for between 5 min and 2 h. Cells were
then harvested in a lysis buffer (25 mmol/L Tris, pH 7.5,
2% SDS, 1 mmol/L EDTA, 1 mmol/L DTT, supplemented
with protease and phosphatase inhibitor cocktails to
10 lL/mL). In another experiment, myotubes were incu-
bated in AA and insulin overnight. The next day, and to
simulate a washout, the cells were starved for 4 h in
serum-free AMEM and then incubated in either AA or an
AA-free medium for 30 min, followed by incubation in
insulin for an additional 30 min. Cells were then harvested
and immunoblot analysis for the indicated antigens was
carried out. In other experiments, after the incubation in
AA and/insulin as described above, insulin-stimulated
glucose transport was conducted (Pimenta et al. 2008).
Rat studies
Young male Sprague–Dawley rats (50–70 g) were pur-
chased from Charles River Laboratories Inc. (Quebec,
Canada). They were left to acclimatize for 1 week in the
animal care facility at York University while being main-
tained at the standard 12:12-h light–dark cycle at 22–23°C.
They had free access to rat chow (product #D12450B,
Research Diets, New Brunswick, NJ) and water. After
acclimatization, the animals were handled 2–3 times per
week in order to reduce stress due to handling on the day
of the experiment. All experiments were approved by the
York University Animal Care Committee and were
performed in accordance with the Canadian Council for
Animal Care guidelines.
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Rats were food deprived for 18 h but had access to
water. They were then divided into three groups (Fig. 1A,
bottom). The first group (control [stv]) was gavaged with
double distilled water at a dose of 2.4 mL/100 g body
weight. The second group was gavaged with leucine (1 g/
50 mL ddH2O, 2.4 mL/100 g body weight). This amount
is equivalent to 0.48 g leucine/kg, and represents ~40% of
a rat’s daily leucine consumption (Serino et al. 2011).
Rats were sacrificed at different times (0.5–2 h) after
gavage and soleus muscle dissected. The third group was
gavaged with leucine and, 2 h later, returned to food.
This group was then again food-deprived overnight and
divided into two subgroups. One subgroup was regavaged
on day 2 with water while the other was gavaged with
leucine. Rats were sacrificed at either 0.5 or 1 h postga-
vage and soleus muscle dissected. To examine whether
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Figure 1. In L6 myotubes, amino acid and insulin induce S6K1 (T389) and IRS-1 (serine residues) phosphorylation in a reversible manner. (A)
Experimental design for myotube (top) and rat (bottom) studies. Studies conducted on day 2 are in dotted boxes. (B, C) Myotubes were
starved for 4 h and then incubated for 30 min in either an amino acid-free solution or AMEM with added leucine to a final concentration of
800 lmol/L (AA). Incubation with AA continued for up to 2 h in the presence or absence of insulin. Cells were harvested and lysates probed
for phosphorylated (B) S6K1 (T389) and (C) IRS-1 (S 307/612/636/639). Data are mean  SD. In (B), *P < 0.05 versus time 0, AA at 60 and
120 min; †P < 0.01 versus time 0, AA at 60 and 120 min; ‡P < 0.05 versus AA at 5 min. In (C), *P < 0.05 versus time 0; †P < 0.01 versus AA
at all time points. (D, E) Phosphorylated and total S6K1 and IRS-1 in myotubes incubated with insulin for different lengths of time. Data are
mean  SD. Bars with different symbols differ from one another (P < 0.05). (F, G) Total S6K1 and IRS-1 in myotubes incubated with leucine-
enriched amino acid (AA) with or without insulin for different lengths of time. Data are mean  SD. In (F), bars with different symbols differ
from one another (P < 0.05). In (G), *P < 0.05 compared to time 0. (H) Myotubes treated as in (B) were incubated in AA and insulin overnight.
They were then starved for 4 h (D2 control) and subjected to AA and insulin stimulation (D2 AA+ins). Cell lysates were probed for
phosphorylated S6K1 and IRS-1. Data are mean  SD, *P ≤ 0.05 versus D2 control.
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the dynamics of regulation of S6K1 and IRS1 might be
different in insulin-resistant state, identical experiments
were conducted in rats fed high-fat diet (60% kcal as fat,
product # D2492, Research Diets) for 8 weeks to render
them insulin resistant.
Insulin tolerance test
Following a 6 h food deprivation, rats were gavaged with
either water or leucine. Thirty minutes following gavage,
blood samples were taken via tail nick and then a subcuta-
neous insulin (Humulin R, Eli Lilly Canada Inc., Toronto,
Ontario, Canada) injection was administered (0.75 U/kg
body weight). Blood samples were collected at various
times postinjection, and the resulting plasma analyzed for
glucose (YSI Glucose/Lactate analyzer), total BCAA (Che-
valier et al. 2004) concentrations, and for insulin using a
commercial kit (Crystal Chem, Downers Grove, IL).
Western blot
Soleus muscle samples were homogenized as described
(Zargar et al. 2011). Equal amount of proteins in the
supernatant fraction was separated by SDS-PAGE. Phos-
phorylated S6K1 (T389) and IRS-1 (S307/612/636/639)
were detected by immunoblotting (Zargar et al. 2011).
Statistical analysis
Data from cell culture studies were analyzed using a one-
way ANOVA and Bonferroni post hoc test (GraphPad
Prism 6.00, GraphPad Software Inc., La Jolla, CA). For
rat studies, S6K1 and IRS-1 data were analyzed by one-way
ANOVA, whereas glucose, BCAA, and insulin were ana-
lyzed by two-way ANOVA and Tukey’s multiple
comparison test. Statistical significance was set at P < 0.05.
Results
Amino acid- and insulin-induced mTORC1
activation and IRS-1 serine phosphorylation
in myotubes are reversible
Incubation of L6 myotubes with a combination of AA
and insulin increased T389 S6K1 (Fig. 1B) and, in a time-
dependent manner, serine phosphorylation of IRS-1
(Fig. 1C). Under the conditions tested, AA alone had no
effect. Insulin by itself stimulated S6K1 phosphorylation
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Figure 1. Continued
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(Fig. 1D) but had no significant effect on IRS-1 serine
phosphorylation (Fig. 1E). In addition, incubation with
AA plus insulin increased S6K1 abundance at the 1 h
time point (Fig. 1F) but no significant effect was seen on
total IRS-1 until 2 h when the abundance of the protein
was increased (Fig. 1G).
To examine the dynamics of these modifications, we
incubated myotubes overnight in a medium that con-
tained both AA and insulin. Following this, the starva-
tion–refeeding experiment was then repeated. As seen in
Figure 1H, T389 S6K1 and IRS-1 serine phosphorylation
was low in starved cells, even though these cells had been
incubated in AA plus insulin overnight. When restimulat-
ed, however, phosphorylation of these proteins was
induced. Therefore, in L6 myotubes, the effect of AA and
insulin in activating S6K1 and inducing serine phosphory-
lation of IRS-1 is reversible.
In myotubes, the inhibitory effect of AA on
insulin-stimulated glucose transport is
reversible
Activation of mTORC1/S6K1 and serine phosphorylation
of IRS-1 have been linked to insulin resistance of glucose
transport. We therefore examined whether the dynamics
we observed in the regulation of these proteins also applied
to their effects on glucose transport. AA suppressed insu-
lin-stimulated glucose transport by 40% (P < 0.01,
Fig. 2A). Next, some of the myotubes were incubated in
AA and insulin overnight, and then starved the next day for
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Figure 2. Impairment of insulin-stimulated glucose transport in myotubes treated with AA + insulin is reversible. (A) Myotubes were starved
for 4 h and then incubated for 30 min in either an amino acid-free solution (Control) or leucine-enriched AA mixture (AA). Following this,
insulin-stimulated glucose transport was measured. In another group, incubation in AA and insulin continued overnight. Cells were then starved
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4 h. Insulin-stimulated glucose transport in these cells was
not different from that observed in the control group
(Fig. 2A). These results suggest that the impairment of
insulin-stimulated glucose uptake in L6 myotubes is a tem-
poral and reversible phenomenon. Finally, the suppressive
effect of AA and insulin on glucose transport is mTORC1
dependent as incubation with rapamycin, an mTORC1
inhibitor, abolished the effect (Fig. 2B).
Because AKT is implicated in insulin-stimulated glu-
cose transport, we examined the regulation of this pro-
tein. AKT T308 and S473 phosphorylation was induced
by insulin (Fig. 2C and D). The effect of insulin on T308
phosphorylation was partially reversibly modified in the
presence of AA.
In lean rats, leucine gavage reversibly
increases soleus muscle phosphorylation of
S6K1 and IRS-1 and suppresses whole body
insulin sensitivity of glucose
To test whether these results could be mimicked in vivo
and in line with the significance of branched chain AA
in promoting insulin resistance (Newgard et al. 2009),
we compared the effect of leucine or water gavage in
young healthy male rats that had been food deprived for
18 h. Thirty minutes after gavage, leucine, but not
water, significantly increased S6K1 T389 (~12-fold,
P < 0.001) and IRS-1 serine phosphorylation (~5-fold,
P < 0.05, Fig. 3A and B) in soleus muscle. A group of
rats that had been gavaged with leucine was returned to
food 2 h after gavage, and then food-deprived overnight.
They were then regavaged with either water or leucine
and sacrificed at various time points. Following over-
night food deprivation after the initial leucine gavage,
S6K1 and IRS-1 phosphorylation was reduced to basal
in rats gavaged with water (referred to as “d2 water” in
Fig. 3A and B).
To determine the functional consequences of these
results, another group of rats was food deprived for 6 h
and then gavaged with either water or leucine. Thirty
minutes later, an insulin tolerance test (ITT) was
conducted. Rats gavaged with leucine had significantly
higher plasma blood glucose concentration only at
15 min from the initiation of ITT (Fig. 3C; mmol/L  SE
values at T0 and T15: Water gavage: 8.2  0.2 vs.
3.9  0.4; Leucine gavage: 7.4  1 vs. 5.2  0.2). A third
group of rats was gavaged with leucine, starved overnight,
and regavaged the next day with water before being
administered the ITT. Blood glucose concentrations were
not different from the values in the group gavaged with
water on day 1 (Fig. 3C).
In young animals, insulin stimulates amino acid utiliza-
tion for protein synthesis and suppresses proteolysis, lead-
ing to a decrease in plasma amino acid concentrations,
especially those of the BCAA (Garlick and Grant 1988;
Luzi et al. 1996). To obtain a measure of the effect of leu-
cine gavage on whole body protein metabolism, we deter-
mined plasma total BCAA concentrations during the ITT.
In response to insulin, plasma BCAA was unchanged in
rats that were gavaged with water. In those that received
leucine gavage, insulin administration rapidly suppressed
plasma BCAA levels and the levels remained low in rats
that were studied on day 2 (Fig. 3D).
In insulin-resistant rats, the effects of
leucine on whole body glucose and amino
acid metabolism are reversible
There is an impairment of insulin signaling in skeletal
muscle of obese insulin-resistant individuals. Since obese
individuals frequently attempt to lose weight by using a
high-protein diet, it was necessary to examine whether
the pattern of response to leucine gavage we saw in lean
animals was preserved in rats made obese/insulin resistant
by high-fat diet feeding. S6K1 and IRS-1 (serine) phos-
phorylation was detected even in soleus muscles of fasted
obese rats. Although these measures increased in response
to leucine gavage, the values were not significantly differ-
ent from basal (Fig. 4A and B). As was done for lean rats,
we also studied on day 2 rats that had been gavaged with
leucine on day 1. As seen in animals studied on day 1,
the effect of leucine gavage on muscle phosphorylation of
S6K1 was not significant (Fig. 4A and B).
Although plasma insulin was higher in obese relative to
lean rats, leucine gavage had no significant effect on this
hormone (Fig. 4C).
Fifteen minutes from the commencement of ITT in
lean rats gavaged with water, plasma glucose was <50% of
time zero value (Fig. 3C). At equivalent time in insulin-
resistant rats gavaged with water, the effect of insulin on
blood glucose concentration was not as marked (mmol/
L  SE at T0 and T15: 8.8  0.2 and 5.8  0.5, compare
Fig. 5A to Fig. 3C), confirming the efficacy of the high-
fat diet in inducing insulin resistance. In obese rats
gavaged with leucine, compared to those that received
water, plasma glucose concentration was significantly
higher at all time points between 10 and 90 min
(Fig. 5A). A group of rats was gavaged with leucine and
then given access to food 2 h after the gavage. When this
group was food-deprived overnight and studied the fol-
lowing day, plasma blood glucose concentrations during
the ITT were not different from the values in the group
that was gavaged with water and studied on day 1
(Fig. 5A).
Plasma BCAA concentrations were higher in obese rats;
in fact, the values in those gavaged with water were
2014 | Vol. 2 | Iss. 7 | e12067
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similar to the peak level seen in lean animals that were
gavaged with leucine (compare Figs. 3D and 5B). Con-
trary to the observations in lean rats, plasma BCAA levels
did not return to basal until 2 h from the start of ITT,
consistent with insulin resistance of whole body protein
metabolism. When rats gavaged with leucine were studied
on day 2, BCAA levels remained at the basal level.
Discussion
Insulin resistance nucleates a number of metabolic dis-
eases, including type 2 diabetes and cardiovascular disease
(DeFronzo 2010), nonalcoholic liver disease (Bugianesi
et al. 2010), and some cancers (Tsugane and Inoue 2010).
Therefore, interventions that improve insulin sensitivity
hold promise for the prevention and/or management of
those conditions. Hence, the possibility that a treatment
used in body weight management (high-protein diet)
could induce insulin resistance has serious clinical impli-
cations. Using in vitro and in vivo approaches, we dem-
onstrated that AA plus insulin (myotube studies) or
leucine (rat studies) reversibly modified S6K1 T389 and
IRS-1 serine phosphorylation in muscle cells and skeletal
muscle, and caused temporal and reversible insulin
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resistance of glucose and amino acid metabolism in both
lean and obese rats.
Although the possible roles of AA in regulating insulin
sensitivity have been proposed since the 1960s (Felig et al.
1969, 1970), it is only in the last few years that the puta-
tive mechanisms that underlie this phenomenon have
been studied (Newgard 2012). Whereas, earlier studies
implicated amino acids and high-protein diets as media-
tors of glucose intolerance, hyperinsulinemia, and insulin
resistance (Lariviere et al. 1994; Linn et al. 2000; Schulze
et al. 2003; Song et al. 2004), others have shown benefi-
cial effects of these diets. These include enhancement of
insulin sensitivity in the elderly (Solerte et al. 2008) and
in obese mice (Macotela et al. 2011), and beneficial effects
against cardiac and skeletal muscle mitochondrial defects
in old rats (D’Antona et al. 2010). A study with >4000
participants of different ethnicities showed that higher
consumption of BCAA is associated with lower prevalence
of overweight/obesity (Qin et al. 2011).
While other mechanisms through which AA may induce
insulin resistance are possible, it is the one mediated by
mTORC1/S6K1 that has been intensively studied. Acti-
vated S6K1 induces phosphorylation of IRS-1 on multiple
serine residues, a modification that not only impedes tyro-
sine phosphorylation of IRS-1 but is also thought to stim-
ulate its degradation. These effects on IRS1 lead to a
quenching of insulin signaling (Tremblay et al. 2007).
Indeed mice that lack S6K1 are protected against diet-
induced insulin resistance (Um et al. 2004). Our data
demonstrating that rapamycin blocked the effect of AA on
glucose transport in myotubes and rat data showing
increased S6K1 activation and IRS-1 serine phosphoryla-
tion along with insulin resistance of glucose metabolism in
response to leucine gavage are consistent with this.
Majority of the studies on insulin resistance typically
focus on glucose metabolism, even though insulin also
regulates protein synthesis and/or breakdown (Marliss
and Gougeon 2002), especially in skeletal muscle of
rodent (Wang et al. 2006; Kimball and Jefferson 2010)
and human whole body studies (Halvatsiotis et al. 2002;
Pereira et al. 2008). In fact, there is some evidence to link
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impaired insulin regulation of protein metabolism, which
would lead to increased availability of free (glucogenic)
AA, to the increased gluconeogenesis observed in insulin-
resistant individuals (Chevalier et al. 2006). Our data on
plasma BCAA showed that when leucine gavage is admin-
istered prior to ITT, the elevated plasma BCAA is rapidly
brought back to normal, consistent with the idea that in
lean rats, these amino acids do not impair insulin sensi-
tivity, as others have shown (Bassil et al. 2011). Obviously
this measure reflects whole body average and does not
allow identification of tissue-specific effect. However,
because increased AA disposal via elevated muscle protein
synthesis is a main effect of insulin (Davis and Reeds
1998; Chevalier et al. 2004), it is likely that the disappear-
ance of AA is linked to insulin-induced stimulation of
muscle protein synthesis. The picture was quite different
in obese insulin-resistant animals. Plasma BCAA was
already elevated in these animals, as has been reported by
others (Newgard et al. 2009; Wang et al. 2011). During
the ITT, the normalization of these AA took markedly
longer (15 min in lean vs. >60 min in obese). Moreover,
the reduction in BCAA in response to insulin was only to
the pre-ITT level, but not to the level seen in lean rats. In
spite of this apparent impairment of whole body insulin
sensitivity of protein metabolism, the alteration is never-
theless reversible. Therefore, leucine administration, and
likely acute dietary protein consumption, in obese indi-
viduals are unlikely to worsen the preexisting insulin
resistance.
At least two mechanisms may explain the reversibility
of mTORC1/S6K1 signaling and IRS-1 serine phosphory-
lation. Specific phosphatases may dephosphorylate these
kinases. For example, protein tyrosine phosphatase-1B
(PTP1B) can dephosphorylate IRS1 (Lazar and Saltiel
2006) while PH domain leucine-rich repeat protein phos-
phatase (PHLPP) (Liu et al. 2011) and B’ regulatory sub-
unit of protein phosphatase 2A (PP2A-B’) (Hahn et al.
2010) have been shown to dephosphorylate S6K1. Com-
pared to the kinases that phosphorylate these proteins,
the phosphatases tend to have broader specificities and
mechanisms of their regulation are relatively poorly
understood. A second mechanism of the reversibility of
signaling to these proteins is targeted proteolysis of phos-
phorylated S6K1 and IRS-1. Ubiquitin protein ligases that
target mTOR (Mao et al. 2008) and IRS-1 (Rui et al.
2002) for degradation by the proteasome have been
described, and there is evidence that S6K1 too may be
degraded by the proteasome (Gao et al. 2009). It will be
interesting to examine whether entities that target them
for degradation are regulated by AA in a manner that can
explain the observed reversible phosphorylation of S6K1
and IRS-1 in response to leucine.
In summary, we provide evidence that AA/leucine-
induced impairment of skeletal muscle insulin signaling
and whole body insulin sensitivity of glucose in healthy rat
is modest and reversible. In obese rats, although leucine
administration further impaired insulin regulation of whole
body glucose and amino acid metabolism, the effects were
reversible. In studies that have attributed insulin resistance
to high-protein diet, leucine is thought to be the main
mediator of this effect, therefore, our data have implica-
tions for human nutrition and management of metabolic
diseases. While these data need to be confirmed in studies
that examine the effects of long-term high dietary protein
intakes, our results suggest that the benefits derivable from
the use of high-protein diets by obese individuals are unli-
kely to be associated with worsening of insulin sensitivity.
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